TODAY'S MARKET INTELLIGENCE
Sinopharm Modern Plan to Acquire 51% of Guorui Pharma for 406M Yuan
English summary
Sinopharm Modern plans to acquire 51% equity of Sinopharm Group Guorui Pharmaceutical for RMB406 million in cash. The related-party transaction, approved by the board, will make Guorui a controlled subsidiary, expanding the company's business.
The English text is machine translated and may require verification against the Chinese version.
Browse today's intelligence